CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes

Journal of Virology

Volumn 86, Issue 12, 2012, Pages 6586-6594

  Kwon, Douglas S ^a,b   Angin, Mathieu ^a   Hongo, Tomoyuki ^a   Law, Kenneth M ^a   Johnson, Jessica ^a   Porichis, Filippos ^a   Hart, Meghan G ^a   Pavlik, David F ^a   Tighe, Daniel P ^a   Kavanagh, Daniel G ^a   Streeck, Hendrik ^a   Addo, Marylyn M ^a,b   Kaufmann, Daniel E ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR DYNAMICS; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL DEPLETION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS LOAD;

CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MONOCYTES; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863993864     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06251-11     Document Type: Article

References (46)

1. Ancuta P, et al. 2001. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J. Immunol. 166:4244-4253.
2. Anderson CF, Stumhofer JS, Hunter CA, Sacks D. 2009. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J. Immunol. 183:4619-4627.
3. Batten M, et al. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180:2752-2756.
4. Blackburn SD, Wherry EJ. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15:143-146.
5. Brockman MA, et al. 2009. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114:346 -356.
6. Brooks DG, et al. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309.
7. Carrington M, Nelson G, O'Brien SJ. 2001. Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol. Lett. 79:131-140.
8. Couper KN, Blount DG, Riley EM. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771-5777.
9. Couper KN, et al. 2008. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 4:e1000004. doi:10.1371/journal. ppat.1000004.
10. Dai WJ, Köhler G, Brombacher F. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158:2259 -2267.
11. Denis M, Ghadirian E. 1993. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151: 5425-5430.
12. de Waal Malefyt R, et al. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924.
13. Ejrnaes M, et al. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203:2461-2472.
14. El-Far M, et al. 2008. T-cell exhaustion in HIV infection. Curr. HIV/AIDS Rep. 5:13-19.
15. Elrefaei M, Barugahare B, Ssali F, Mugyenyi P, Cao H. 2006. HIVspecific IL-10-positive CD8+ T cells are increased in advanced disease and are associated with decreased HIV-specific cytolysis. J. Immunol. 176: 1274-1280.
16. Elrefaei M, et al. 2009. TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells. PLoS One 4:e8194. doi:10.1371/journal.pone.0008194.
17. Elrefaei M, et al. 2007. HIV-specific IL-10-positive CD8+ T cells suppress cytolysis and IL-2 production by CD8+ T cells. J. Immunol. 178: 3265-3271.
18. Erikstrup C, et al. 2007. Reduced mortality and CD4 cell loss among carriers of the interleukin-10-1082G allele in a Zimbabwean cohort of HIV-1-infected adults. AIDS 21:2283-2291.
19. Fitzgerald DC, et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8:1372-1379.
20. Graziosi C, et al. 1994. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265:248 -252.
21. Guzzo C, Che Mat NF, Gee K. 2010. Interleukin-27 induces a STAT1/3-and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem. 285:24404 -24411.
22. Iyer SS, Ghaffari AA, Cheng G. 2010. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 185:6599-6607.
23. Kang KH, Im SH. 2005. Differential regulation of the IL-10 gene in Th1 and Th2 T cells. Ann. N. Y. Acad. Sci. 1050:97-107.
24. Kaufmann DE, et al. 2007. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8:1246 -1254.
25. Kaufmann DE, Walker BD. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182:5891-5897.
26. Kishore R, Tebo JM, Kolosov M, Hamilton TA. 1999. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162:2457-2461.
27. Knapp S, et al. 2003. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55:362-369.
28. Kwon DS, Kaufmann DE. 2010. Protective and detrimental roles of IL-10 in HIV pathogenesis. Eur. Cytokine Netw. 21:208 -214.
29. Miyazoe S, et al. 2002. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 97:2086 -2092.
30. Naicker DD, et al. 2009. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J. Infect. Dis. 200:448-452.
31. Pflanz S, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779 -790.
32. Powell MJ, Thompson SA, Tone Y, Waldmann H, Tone M. 2000. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region. J. Immunol. 165:292-296.
33. Reed SG, et al. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:3135-3140.
34. Rodríguez-García M, et al. 2011. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J. Leukoc. Biol. 89:507-515.
35. Rouse BT, Sarangi PP, Suvas S. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212:272-286.
36. Said EA, et al. 2010. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16:452- 459.
37. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10:170 -181.
38. Shin H, Wherry EJ. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19:408-415.
39. Shin HD, et al. 2000. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl. Acad. Sci. U. S. A. 97:14467-14472.
40. Sozzani S, et al. 1998. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187:439-444.
41. Stoecklin G, et al. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283:11689 - 11699.
42. Stylianou E, Aukrust P, Kvale D, Müller F, Frøland SS. 1999. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression- down-regulatory effect of potent anti-retroviral therapy. Clin. Exp. Immunol. 116:115-120.
43. Trabattoni D, et al. 2003. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101:2514 - 2520.
44. Virgin HW, Wherry EJ, Ahmed R. 2009. Redefining chronic viral infection. Cell 138:30 -50.
45. Weiss L, et al. 2004. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249 - 3256.
46. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911- 4927.